| REVIEW ARTICLE |
|
| Year : 2016 | Volume
: 7
| Issue : 4 | Page : 161-164 |
|
|
Trends in clinical trials of dengue vaccine
Priya Marimuthu, Jamuna Rani Ravinder
Department of Pharmacology, SRM Medical College, Kattankulathur, Kanchipuram, Tamil Nadu, India
Correspondence Address:
Priya Marimuthu
Department of Pharmacology, SRM Medical College, Kattankulathur, Kanchipuram - 603 203, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2229-3485.192035
|
|
|
Dengue is one of the most important vector-borne disease and an increasing problem worldwide because of current globalization trends. Roughly, half the world's population lives in dengue endemic countries, and nearly 100 million people are infected annually with dengue. India has the highest burden of the disease with 34% of the global cases. In the context of an expanding and potentially fatal infectious disease without effective prevention or specific treatment, the public health value of a protective vaccine is clear. There is no licensed dengue vaccine is available still, but several vaccines are under development. Keeping in view the rise in dengue prevalence globally, there is a need to increase clinical drug and vaccine research on dengue. This paper briefly reviews on the development and current status of dengue vaccine to provide information to policymakers, researchers, and public health experts to design and implement appropriate vaccine for prophylactic intervention. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
